Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)
This study has been completed.
Study NCT00653341   Information provided by Sanofi

First Received on April 1, 2008.   Last Updated on April 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
insulin glargine
NPH human insulin
Additional drug interventions recognized in this trial
Glargine
Hypoglycemic Agents
Insulin
Insulin, Long-Acting
Insulin, NPH
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services